Biora Therapeutics (NASDAQ:BIOR) Trading Down 1.5%

Biora Therapeutics, Inc. (NASDAQ:BIOR)’s share price traded down 1.5% during mid-day trading on Tuesday . The company traded as low as $0.73 and last traded at $0.74. 113,447 shares were traded during mid-day trading, a decline of 73% from the average session volume of 417,669 shares. The stock had previously closed at $0.75.

Biora Therapeutics Stock Down 1.5 %

The business’s 50-day moving average price is $0.91 and its 200 day moving average price is $1.14. The company has a market capitalization of $26.57 million, a P/E ratio of -0.09 and a beta of 1.22.

Biora Therapeutics (NASDAQ:BIOR) last announced its quarterly earnings results on Tuesday, March 26th. The company reported ($0.63) EPS for the quarter, missing the consensus estimate of ($0.60) by ($0.03). Analysts anticipate that Biora Therapeutics, Inc. will post -1.46 EPS for the current fiscal year.

Biora Therapeutics Company Profile

Biora Therapeutics, Inc, a biotechnology company, engages in developing oral biotherapeutics. The company's targeted therapeutics program uses an ingestible smart capsule for targeted delivery of therapeutics in the gastrointestinal (GI) tract to enhance the treatment of inflammatory bowel diseases; and Systemic oral delivery platform for oral delivery of large molecules for management of chronic diseases.